INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1
-
Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic CancerBeriwal, Sushil / Klopp, Ann / Mell, Loren et al. | 2017
- 5
-
Clinical Development of Cancer Drugs in Combination With External Beam Radiation Therapy: US Food and Drug Administration PerspectiveWalker, Amanda J. / Kim, Hyun / Saber, Haleh et al. | 2017
- 8
-
Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic DatasetsChen, William S. / Townsend, Jeffrey P. / Yu, James B. et al. | 2017
- 11
-
Adjuvant Therapy in High-Risk Stage III Cutaneous MelanomaBarker, Christopher A. et al. | 2017
- 13
-
Encourage Enrollment in Clinical Trials of Neoadjuvant or Adjuvant Systemic Therapy, and Consider Adjuvant Radiation Therapy to Prevent Morbid RecurrenceAnker, Christopher J. et al. | 2017
- 13
-
Radiation Therapy Followed by Ipilimumab Is AppropriateCooper, Jay S. et al. | 2017
- 15
-
Consider Adjuvant Intensity Modulated Radiation Therapy to the Lymph Node Basin, Especially If the Melanoma Is BRAF Wild TypeFoote, Matthew et al. | 2017
- 16
-
Adjuvant and Neoadjuvant Therapy in High-Risk Stage III Cutaneous MelanomaSondak, Vernon K. / Khushalani, Nikhil I. et al. | 2017
- 18
-
The Ever-Evolving Role of the Academic Clinical PhysicistKlein, Eric E. / Fontenot, Jonas / Dogan, Nesrin et al. | 2017
- 21
-
Nature of Medical Malpractice Claims Against Radiation OncologistsMarshall, Deborah / Tringale, Kathryn / Connor, Michael et al. | 2017
- 31
-
Female Representation in the Academic Oncology Physician Workforce: Radiation Oncology Losing Ground to Hematology OncologyAhmed, Awad A. / Hwang, Wei-Ting / Holliday, Emma B. et al. | 2017
- 34
-
Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy TrialsRitter, Timothy A. / Matuszak, Martha / Chetty, Indrin J. et al. | 2017
- 37
-
Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric PatientsGiantsoudi, Drosoula / Seco, Joao / Eaton, Bree R. et al. | 2017
- 47
-
Water Exchange Rate Constant as a Biomarker of Treatment Efficacy in Patients With Brain Metastases Undergoing Stereotactic RadiosurgeryMehrabian, Hatef / Desmond, Kimberly L. / Chavez, Sofia et al. | 2017
- 56
-
Quantitative Approach to Failure Mode and Effect Analysis for Linear Accelerator Quality AssuranceO'Daniel, Jennifer C. / Yin, Fang-Fang et al. | 2017
- 63
-
Later Life Changes in Hippocampal Neurogenesis and Behavioral Functions After Low-Dose Prenatal Irradiation at Early Organogenesis StageGanapathi, Ramya / Manda, Kailash et al. | 2017
- 75
-
Local Hypothermia as a Radioprotector of the Rectal Wall During Prostate Stereotactic Body Radiation TherapyHrycushko, Brian A. / Chopra, Rajiv / Sayre, James W. et al. | 2017
- 83
-
Tolerance of the Brachial Plexus to High-Dose ReirradiationChen, Allen M. / Yoshizaki, Taeko / Velez, Maria A. et al. | 2017
- 91
-
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial MetastasesWang, Chiachien Jake / Christie, Alana / Lin, Mu-Han et al. | 2017
- 101
-
Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate CancerGestaut, Matthew M. / Cai, Wendi / Vyas, Shilpa et al. | 2017
- 108
-
Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate CancerHauck, Carlin R. / Ye, Hong / Chen, Peter Y. et al. | 2017
- 115
-
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentHafeez, Shaista / McDonald, Fiona / Lalondrelle, Susan et al. | 2017
- 123
-
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsPollom, Erqi L. / Fujimoto, Dylann / Wynne, Jacob et al. | 2017
- 131
-
Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery AloneFarris, Michael / McTyre, Emory R. / Cramer, Christina K. et al. | 2017
- 142
-
Dry Eye Syndrome After Proton Therapy of Ocular MelanomasThariat, Juliette / Maschi, Celia / Lanteri, Sara et al. | 2017
- 152
-
Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal MelanomaYazici, Gozde / Kiratli, Hayyam / Ozyigit, Gokhan et al. | 2017
- 159
-
Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years LaterHuang, Shao Hui / Waldron, John / Bratman, Scott V. et al. | 2017
- 170
-
Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal CarcinomaChen, Yu-Pei / Chen, Lei / Li, Wen-Fei et al. | 2017
- 177
-
The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell CarcinomaPollom, Erqi L. / Wang, Guanying / Harris, Jeremy P. et al. | 2017
- 186
-
Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal CarcinomaMcDowell, Lachlan J. / Huang, Shao Hui / Xu, Wei et al. | 2017
- 196
-
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationRahimi, Asal / Thomas, Kimberly / Spangler, Ann et al. | 2017
- 206
-
Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After MastectomyGrellier Adedjouma, Noemie / Chevrier, Marion / Fourquet, Alain et al. | 2017
- 215
-
In Regard to Dr VapiwalaJennelle, Richard / Chang, Eric L. et al. | 2017
- 215
-
In Reply to Jenelle and ChangVapiwala, Neha et al. | 2017
- 216
-
In Regard to Shaverdian et alScott, E. Michael D. et al. | 2017
- 217
-
In Reply to ScottShaverdian, Narek / Steinberg, Michael L. / King, Christopher R. et al. | 2017
- 218
-
Table of Contents| 2017
- 219
-
Planning Committees| 2017
- 220
-
Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance BiopsyPiotrowska, Z. / Stirling, K. / Heist, R. et al. | 2017
- 220
-
Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance)Edelman, M.J. / Wang, X. / Hodgson, L. et al. | 2017
- 221
-
Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated with Chemoradiation TherapyChinniah, C. / Aguarin, L. / Cheng, P. et al. | 2017
- 221
-
A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non–Small Cell Lung CancerSingh, A.K. / Suescun, J. A. Gomez / Stephans, K.L. et al. | 2017
- 222
-
Reirradiation of Thoracic Cancers with Intensity Modulated Proton TherapyHo, J.C. / Nguyen, Q.N. / Li, H. et al. | 2017
- 222
-
Individualizing Radiation Dose in Locally Advanced Non–Small Cell Lung Cancer Patients Using Pretreatment Serum MicroRNA SignaturesJolly, S. / Sun, Y. / Hawkins, P.G. et al. | 2017
- 223
-
Indications for Invasive Mediastinal Staging in Patients with Early Non–Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed TomographyGao, S. / Kim, A. / Puchalski, J. et al. | 2017
- 223
-
Racial Disparities in the Treatment and Outcome of Stage I Non–Small Cell Lung CancerDalwadi, S.M. / Lewis, G. / Butler, E.B. et al. | 2017
- 223
-
Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung CancerSepesi, B. / Cuentes, E. Parra / Canales, J.R. et al. | 2017
- 224
-
Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung CancerAhmed, K.A. / Grass, G.D. / Creelan, B. et al. | 2017
- 224
-
Impact of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small Cell Lung Cancer: A Propensity Score Matched Analysis of Patients in the National Cancer DatabaseSharma, S. / McMillan, M. / Doucette, A. et al. | 2017
- 225
-
Standardization of Radiation Therapy Dose for Locally Advanced Non–Small Cell Lung Cancer Through Changes to a Lung Cancer Clinical Pathway in a Large, Integrated Comprehensive CancerCenter NetworkGebhardt, B.J. / Horne, Z.D. / Heron, D.E. et al. | 2017
- 225
-
Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non–Small Cell Lung Cancer Patients Treated with Proton TherapyZhu, H.J. / Nichols, R.C. / Henderson, R.H. et al. | 2017
- 226
-
Pulmonary Artery Sarcoma: 19-Year Cohort StudySrivali, N. / Yi, E.S. / Ryu, J. et al. | 2017
- 226
-
Comparison of Tumor Volumes as Determined by Pathologic Examination and FLT-PET/CT Images of Non–Small Cell Lung Cancer: A Pilot StudyGao, Z. / Meng, X. / Chen, X. et al. | 2017
- 226
-
Multidisciplinary Care and the Use of Treatment Modalities for Non–Small Cell Lung Cancer (NSCLC) in a Large Community Healthcare SettingRay, M. / Faris, N. / Rugless, F. et al. | 2017
- 227
-
Non–Small Cell Lung Cancer: Does Histology Matter?Nagasaka, M. / Sukari, A. et al. | 2017
- 227
-
IGRT for Lung SBRT: MVCT Versus kV-CBCTBaran, G. / Bossenberger, T. / Burmeister, J.W. et al. | 2017
- 228
-
Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung CancerQin, A. / Street, L. / Viglianti, B.L. et al. | 2017
- 228
-
Prognostic Significance of and the Relationship Between Tumor-infiltrating and Circulating Lymphocytes to Macrophage/Monocyte Ratio in Patients With Esophageal Squamous Cell Cancer of Pathological Stage T3N0M0Zhu, Y. / Li, M. / Bo, C. et al. | 2017
- 228
-
CD8+/FOXP3+ Ratio and PD-L1 Expression Associated With Survival in pT3N0M0 Stage Esophageal Squamous Cell CancerZhu, Y. / Li, M. / Mu, D. et al. | 2017
- 229
-
A Single-Institution Experience in Treating Thymic CarcinomaMohiuddin, I. / Allen, B.G. et al. | 2017
- 229
-
Stereotactic Body Radiation Therapy for Early Stage Non–Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center AnalysisCassidy, R.J. / Patel, P.R. / Zhang, X. et al. | 2017
- 229
-
Post-operative Radiation Therapy in Locally Invasive Malignancies of the Thymus: Patterns of Care and SurvivalBoothe, D. / Orton, A. / Thorpe, C. et al. | 2017
- 230
-
Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non–Small Cell Lung cancer: An Analysis of the National Cancer Data BasePezzi, T.A. / Mohamed, A.S.R. / Fuller, C.D. et al. | 2017
- 230
-
Stereotactic Body Radiation Therapy for ≥5 cm Non–Small Cell Lung Cancer: Survey of United States Academic Thoracic Radiation OncologistsPost, C.M. / Verma, V. / Zhen, W. et al. | 2017
- 230
-
Stereotactic Body Radiation Therapy Outcomes for Early Stage and Oligometastatic Non–Small Cell Lung Cancer Based on Molecular ProfileBlumenfeld, P.A. / Kreinbrink, P.J. / Marwaha, G. et al. | 2017
- 231
-
A Review of Non–Small Cell Lung Cancer Post-Treatment Follow-up Imaging Procedures with PET/CT Scans Versus CT Scans and the Effect on Patient SurvivalMansueti, J.R. / Maillie, S. et al. | 2017
- 231
-
Outcome with Stereotactic Body Radiation Therapy for Stage I Non–Small Cell Lung Cancer Using 5 Fractions: Single Institution Experience of 106 Consecutive PatientsSingh, D.P. / Bergsma, D.P. / Cummings, M.A. et al. | 2017
- 232
-
Optimal Patient Selection for Stereotactic Body Radiation Therapy: A Practical Approach in a High-Volume Community-Based Private SettingYap, J. / Chen, W. / Shanbhag, V. et al. | 2017
- 232
-
Active Surveillance for Elderly Stage IA Non–Small Cell Lung Cancer PatientsNo, H. / Kikut, J. / Garrison, G. et al. | 2017
- 232
-
Is Radiation Fall-off Dose to the Uninvolved Lung Important? The Impact of Pre-Operative Contralateral Lung Radiation Dose on Post-Operative Pulmonary ToxicityGuo, W. / Hui, X. / Alfaifi, S. et al. | 2017
- 233
-
Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer PET/CT Imaging Using 18F-FDG and 18F-FLT in Non–Small Cell Lung Cancer Patients: A Prospective Pilot StudyLiu, J. / Li, C. / Hu, M. et al. | 2017
- 233
-
Comparison of Radiation Dose of Induction Chemoradiation Therapy Followed by Surgery for Potentially Resectable Stage III Non–Small Cell Lung CancerTakehana, K. / Inokuchi, H. / Tsutsui, K. et al. | 2017
- 234
-
A Formal Assessment of the Dosimetric Advantages of Intensity-Modulated Radiation Therapy in Locally Advanced Lung CancerAckerson, B. / Boyle, J.M. / Gu, L. et al. | 2017
- 234
-
Prospective Study of Marginal Recurrence in Patients with Non–Small Cell Lung Cancer After Proton or Photon Chemoradiation TherapyYang, P. / Liao, Z. / Gomez, D.R. et al. | 2017
- 234
-
Photon Volumetric Modulated Arc Therapy Versus Intensity Modulated Proton Therapy Versus Intensity Modulated Carbon Ion Therapy in the Delivery of Hypofractionated Thoracic Radiation TherapyChi, A. / Lin, L.C. / Wen, S. et al. | 2017
- 235
-
Low but not High GPA Scores are Associated with Survival Benefits in Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancers with Brain Metastases Receiving Upfront Brain IrradiationLiu, Y. / Deng, L. / Zhou, X. et al. | 2017
- 235
-
Prediction of Early Response to Chemoradiation Therapy in Non–Small Cell Lung Cancer by Using Cone Beam Computed Tomography–Based Tumor Volume and Density ChangesWen, Q. / Meng, X. / Yue, J. et al. | 2017
- 235
-
A Histologic Guide in Treating Stage III Non–Small Cell Lung Cancer: A Single Institution Retrospective AnalysisAljumaily, R. / Pleat, N. / George, S. et al. | 2017
- 236
-
Clinical Outcomes of Stereotactic Body Radiation Therapy Using Flattening Filter Free (FFF) in Early Non–Small Cell Lung Cancers and Metastatic Lung CancersKitpanit, S. / Songthong, A. / Chakkabat, C. et al. | 2017
- 236
-
Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 ResultsGentzler, R.D. / Mohindra, N.A. / Hanna, N. et al. | 2017
- 237
-
Mediastinal/Hilar Stereotactic Ablative Radiation Therapy for Primary and Oligorecurrent Non–Small Cell Lung CancerHorne, Z.D. / Richman, A. / Clump, D.A. et al. | 2017
- 237
-
Attrition in the Treatment of Metastatic Non–Small Cell Lung CancerYang, F. / Chen, L. / Cheung, W. et al. | 2017
- 237
-
Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies?Nguyen, Q.N. / LU, Y. / Tang, C. et al. | 2017
- 237
-
Low Expression of 12 DNA Repair Genes was Associated With Better Disease-free Survival in Non–Small Cell Lung Cancer Patients Having Adjuvant ChemotherapyMo, X. et al. | 2017
- 238
-
Stereotactic Robotic Radiosurgery for 1-3 Brain Metastases from Non–Small Cell Lung Cancer: A Single Institutional Experience from South IndiaG, L. / Agarwal, V. / Swamy, K. et al. | 2017
- 238
-
Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non–Small Cell Lung CancerDavis, K.L. / Lenz, C. / Houghton, K. et al. | 2017
- 239
-
Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non–Small Cell Lung Cancer Patients with Brain MetastasesDavis, K.L. / Lenz, C. / Houghton, K. et al. | 2017
- 239
-
Endo-Bronchial Valve Placement to Manage Bronchopleural Fistula in Patients with Primary Pulmonary NeoplasmNader, D. / Kucinski, J. et al. | 2017
- 239
-
Case Series of MET Exon 14 Skipping Mutation-positive Non–Small Cell Lung Cancers and Response to CrizotinibWang, S.X. / Zhang, B. / Wakelee, H.A. et al. | 2017
- 240
-
Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary ResectionAntonoff, M. / Ragalie, W. / Sepesi, B. et al. | 2017
- 240
-
Estimating the Need for Palliative Radiation Therapy for Lung Cancer: A Benchmarking ApproachJin, C.J. / Kong, W. / MacKillop, W. et al. | 2017
- 241
-
It Wasn't as Bad as I Thought It Would Be: A Prospective, Qualitative Longitudinal Study of Early Stage Non–Small Cell Lung Cancer Patients After TreatmentGolden, S. / Thomas, C.R. / Slatore, C. et al. | 2017
- 241
-
Survival is Increasing for Patients with Stage I Non–Small Cell Lung Cancer Treated With Primary Radiation Therapy: We are Making Progress in the Era of Stereotactic Body Radiation TherapyShin, J. / Russo, G.A. et al. | 2017
- 241
-
Patient Reported Distress and Financial Toxicity in Patients Receiving Thoracic Radiation TherapyStrong, G. / Hintenlang, L. / Jagadesh, N. et al. | 2017
- 242
-
Treatment Patterns of Lung Neuroendocrine Tumors (NETs)Broder, M.S. / Chang, E. / Cai, B. et al. | 2017
- 242
-
Lung Cancer Screening in a Predominantly African-American PopulationErkmen, C. / Mitchell, M. et al. | 2017
- 243
-
Evaluation of Clinical and Demographic Factors Associated with Platinum-Sensitivity Status and Survival in Limited-Stage Small Cell Lung Cancer PatientsWen, Q. / Meng, X. / Sun, X. et al. | 2017
- 243
-
Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes AnalysisRountree, C.A. / Zahra, A. / Russo, J.K. et al. | 2017
- 244
-
What to Do When That Unbiopsied PET-Avid SBRT-Treated Peripheral Lung Mass Recurs in the Mediastinum as Small Cell CarcinomaHolland, J.M. / Walker, J. / Rhodes, S. et al. | 2017
- 244
-
Initial Experience With Fentanyl Iontophoretic Transdermal System in Robotic Thoracic Surgical PatientsBaik, P. et al. | 2017
- 244
-
Hyperfractionated Accelerated Radiation Therapy May Increase Risk for Brain Metastases in Small Cell Lung CancerZeng, H. / Li, R. / Hu, C. et al. | 2017
- 245
-
Validation of 18F-FLT PET as an Imaging Surrogate of Tumor Reproliferation During Fractionated Radiation Therapy: Spatial Coincidence of 8F-FLT Uptake and Immunohistochemistry Ki-67Meng, X. / Zhang, X. / Sun, X. et al. | 2017
- 245
-
Treatment-Related Toxicity in Patients with Early Stage Non–Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic ReviewChen, H. / Senan, S. / Nossent, E.J. et al. | 2017
- 245
-
Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non–Small-Cell Lung Cancer Treated with Definitive Chemoradiation TherapyXu, T. / Xu, Y. / Huo, J. et al. | 2017
- 246
-
Lung Stereotactic Body Radiation Therapy in the Very Elderly (>80 Years Old): Extremely Safe and EffectiveKreinbrink, P. / Blumenfeld, P.A. / Tolekidis, G. et al. | 2017
- 246
-
Dosimetric Analysis of Randomized Proton and Photon Plans with Respect to Radiation Toxicity: The Importance of High Dose Regions in Lung and EsophagusDeist, T.M. / Yang, P. / Oberije, C. et al. | 2017
- 247
-
Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer PatientsNi, L. / Koshy, M. / Connell, P.P. et al. | 2017
- 247
-
Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung CancerSoni, P.D. / Boonstra, P.S. / Schipper, M. et al. | 2017
- 248
-
Patterns of Failure in Metastatic Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Implications for the Role of Definitive Local Therapy to the Primary TumorGuttmann, D.M. / Doucette, A. / Gabriel, P.E. et al. | 2017
- 248
-
Exhaled Nitric Oxide Breath Analysis Used for Predicting Development of Lung Injury After Chest Radiation TherapyNader, D. et al. | 2017
- 248
-
Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung CarcinomaAherne, N. / Tune, D. / Ross, A. et al. | 2017
- 249
-
Association Between LGALS3 Gene Polymorphisms and Survival in Non–Small Cell Lung Cancer Patients Treated With Definitive Radiation TherapyLan, M. / Xu, T. / Gomez, D.R. et al. | 2017
- 249
-
Using Pretreatment Radiomics and Delta-Radiomics Features to Predict Non–Small Cell Lung Cancer Patient OutcomesFave, X. / Zhang, L. / Yang, J. et al. | 2017
- 250
-
Effects of Motion on Radiomics Analysis of Thoracic CancersYin, F.F. / Lafata, K. / Hong, J.C. et al. | 2017
- 250
-
Peripheral Blood Cell Free DNA to Monitor Mutational Response in Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung CancerDevitt, M. / Hall, R. / Gentzler, R.D. et al. | 2017
- 250
-
Clinical Outcomes Following Stereotactic Body Radiation Therapy to Multiple Sites of Intrathoracic DiseaseGoodman, C. / Dalal, P. / Cutright, D. et al. | 2017
- 251
-
Development of a Transcriptomic Signature Associated With Lung Adenocarcinoma Recurrence and SurvivalBrooks, E.D. / Micevic, G. / Chang, J.Y. et al. | 2017
- 251
-
Patterns of Care and Survival Outcomes in Stage II Non–Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseYan, S.X. / Qureshi, M.M. / Truong, M.T. et al. | 2017
- 252
-
Index of Authors| 2017
- 253
-
Meetings| 2017
- A15
-
Issue Highlights| 2017